tiprankstipranks
Medical Facilities Corporation (TSE:DR)
TSX:DR

Medical Facilities (DR) AI Stock Analysis

Compare
74 Followers

Top Page

TS

Medical Facilities

(TSX:DR)

71Outperform
Medical Facilities Corporation has a solid foundation with strong profitability and valuation metrics. However, the recent revenue decline and weak technical indicators pose concerns. The company's strategic asset sales and shareholder returns bolster its financial position, but attention to revenue growth and operational challenges is necessary to maintain momentum.

Medical Facilities (DR) vs. S&P 500 (SPY)

Medical Facilities Business Overview & Revenue Model

Company DescriptionMedical Facilities (DR) is a company operating in the healthcare sector, primarily focused on owning and managing surgical facilities. The company provides a range of services including outpatient surgery, diagnostics, and other related healthcare services. Their facilities are designed to offer high-quality medical care in a cost-effective manner, catering to both patients and healthcare providers.
How the Company Makes MoneyMedical Facilities generates revenue primarily through the operation of its surgical facilities. The company earns money by providing surgical and diagnostic services to patients, with reimbursement from insurance companies, government programs, and patient payments. Key revenue streams include fees for surgical procedures, diagnostic services, and other ancillary services offered at their facilities. Additionally, the company may benefit from partnerships with clinics, hospitals, and healthcare providers, as well as potential agreements with insurance companies to secure patient flow and ensure steady revenue streams.

Medical Facilities Financial Statement Overview

Summary
Medical Facilities shows strong profitability and cash flow generation capabilities, with improvements in net profit margin and return on equity. However, the recent revenue decline is a concern despite the stable balance sheet and solid cash flows. Continued focus on revenue growth and asset management will be crucial to maintain financial health.
Income Statement
65
Positive
The company's revenue has shown fluctuations with a notable decline in 2024, reducing from $445.58M in 2023 to $331.53M in 2024. Despite this, the gross profit margin is relatively strong at approximately 66.3% in 2024. The net profit margin improved significantly to about 22.16% in 2024, indicating effective cost management. However, the revenue growth trajectory is concerning due to the recent drop.
Balance Sheet
70
Positive
The balance sheet reflects a moderate debt-to-equity ratio of 0.61 in 2024, suggesting a balanced approach to leveraging. The return on equity has improved significantly to around 60.24% in 2024, showcasing impressive profitability from the equity base. Equity ratio is 35.23%, indicating a stable financial structure. However, the decrease in total assets over recent years indicates potential asset management challenges.
Cash Flow
75
Positive
Operating cash flow has been consistently strong, with a notable increase to $83.28M in 2024. Free cash flow growth is robust, increasing to $76.22M in 2024. The operating cash flow to net income ratio is favorable, indicating efficient cash conversion. However, reliance on operating cash flow amidst revenue decline could be a potential risk.
Breakdown
Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
331.53M445.58M424.55M398.63M363.85M
Gross Profit
219.88M296.68M280.63M268.61M242.94M
EBIT
61.64M67.11M46.94M77.36M67.79M
EBITDA
82.57M90.36M67.70M103.40M96.05M
Net Income Common Stockholders
73.49M18.50M12.29M46.49M37.42M
Balance SheetCash, Cash Equivalents and Short-Term Investments
108.50M24.11M34.93M61.04M66.18M
Total Assets
346.29M354.88M377.79M446.97M457.00M
Total Debt
73.94M116.81M142.95M140.90M161.95M
Net Debt
-34.56M92.70M108.03M79.86M95.77M
Total Liabilities
198.84M236.58M263.10M267.29M281.83M
Stockholders Equity
122.02M85.99M79.13M134.08M127.53M
Cash FlowFree Cash Flow
76.22M56.66M50.30M67.22M79.57M
Operating Cash Flow
83.28M72.71M57.01M75.64M87.09M
Investing Cash Flow
85.42M-13.67M-5.78M-8.69M18.31M
Financing Cash Flow
-84.26M-69.83M-77.35M-72.06M-71.15M

Medical Facilities Technical Analysis

Technical Analysis Sentiment
Positive
Last Price16.59
Price Trends
50DMA
16.56
Positive
100DMA
16.02
Positive
200DMA
14.71
Positive
Market Momentum
MACD
-0.18
Negative
RSI
55.77
Neutral
STOCH
74.04
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:DR, the sentiment is Positive. The current price of 16.59 is above the 20-day moving average (MA) of 16.17, above the 50-day MA of 16.56, and above the 200-day MA of 14.71, indicating a bullish trend. The MACD of -0.18 indicates Negative momentum. The RSI at 55.77 is Neutral, neither overbought nor oversold. The STOCH value of 74.04 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:DR.

Medical Facilities Peers Comparison

Overall Rating
UnderperformOutperform
Sector (48)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
TSDRX
82
Outperform
C$208.29M3.9136.75%0.41%19.21%105.30%
TSLIF
78
Outperform
C$1.88B10.7626.88%10.16%3.67%-6.05%
TSEXE
74
Outperform
C$1.09B14.5670.86%3.71%12.36%123.26%
TSDR
71
Outperform
$380.31M2.7123.77%2.23%-24.96%549.36%
TSCOV
71
Outperform
C$59.77M11.9419.57%38.28%
TSSIA
61
Neutral
C$1.53B32.988.99%5.60%13.72%429.22%
48
Neutral
$6.86B1.11-50.22%2.47%16.71%1.53%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:DR
Medical Facilities
16.69
6.45
63.02%
TSE:DRX
ADF Group Inc. SV
7.23
-1.67
-18.76%
TSE:EXE
Extendicare
13.30
6.39
92.47%
TSE:SIA
Sienna Senior Living
16.72
4.42
35.93%
TSE:COV
Covalon Technologies
2.20
0.96
77.42%
TSE:LIF
Labrador Iron Ore
29.46
2.94
11.09%

Medical Facilities Earnings Call Summary

Earnings Call Date: Mar 13, 2025 | % Change Since: -0.87% | Next Earnings Date: May 8, 2025
Earnings Call Sentiment Positive
The earnings call reflected a strong financial position due to strategic asset sales and effective cash management, with significant shareholder returns. However, the company faced challenges in revenue growth and incurred an impairment charge, indicating areas for improvement.
Highlights
Sale of Black Hills to Sanford Health
MFC completed the sale of Black Hills to Sanford Health, receiving cash proceeds of $96.1 million. This significantly strengthened the company's balance sheet and resulted in the elimination of $17 million in exchangeable interest related to Black Hills.
Record High Cash Balance
Year-end cash balance reached a record high of $108.5 million, enhancing the company's ability to return capital to shareholders and focus on core assets.
Share Repurchase Program Success
Through substantial issuer bids and normal course issuer bids, MFC repurchased approximately 5.1 million shares, returning $126.2 million to shareholders since 2022.
Recognition of Quality Care
Arkansas Surgical Hospital received the 2024 Press Ganey Human Experience Guardian of Excellence Award for outstanding patient experience, and both Arkansas and Sioux Falls facilities were recognized as top orthopedic hospitals for women.
Lowlights
Decrease in Facility Service Revenue
Fourth quarter facility service revenue declined by 1.1% to $91.1 million, driven by slightly lower surgical case volumes due to physician absences and a temporary intravenous saline fluid shortage.
Impairment Charge on Goodwill
A $2.3 million impairment charge was recorded against goodwill related to the Newport ASC due to a continued competitive environment and local dynamics.
Increase in Operating Expenses
Consolidated salaries and benefits increased by 4.8% due to higher clinical and non-clinical salaries, annual merit increases, and market wage pressures.
Company Guidance
During the 2024 fourth quarter earnings call for Medical Facilities Corporation, key metrics indicated a robust financial performance and strategic shifts. The company completed the sale of Black Hills to Sanford Health, generating $96.1 million in cash proceeds and eliminating $17 million in exchangeable interest, which significantly bolstered their balance sheet with a record-high cash balance of $108.5 million. Medical Facilities repurchased approximately 1.7 million shares for $16.6 million under their normal course issuer bid and conducted a substantial issuer bid, buying back 3.4 million shares for CAD60.7 million, representing 14.7% of their outstanding shares. Their facility service revenue for the year increased by 1.1% to $331.5 million, while income from operations rose by 10.5% to $54.7 million, and adjusted EBITDA grew by 7.3% to $71.4 million. In the fourth quarter, however, facility service revenue slightly declined by 1.1% to $91.1 million due to lower surgical volumes, which were impacted by physician absences and an industry-wide intravenous saline fluid shortage. Nonetheless, the company maintained a strong focus on shareholder returns, operational excellence, and continued debt reduction, retiring the entire $16 million corporate credit facility balance during the year.

Medical Facilities Corporate Events

Dividends
Medical Facilities Corporation Declares First Quarter Dividend
Positive
Mar 21, 2025

Medical Facilities Corporation has announced a cash dividend of Cdn $0.09 per common share, payable on April 15, 2025, to shareholders of record as of March 31, 2025. This announcement reflects the company’s ongoing commitment to providing shareholder value and may influence investor perceptions positively, reinforcing its stable financial health and strategic positioning in the healthcare industry.

M&A TransactionsStock BuybackBusiness Operations and StrategyFinancial Disclosures
Medical Facilities Corporation Strengthens Financial Position with Strategic Sale and Share Repurchase
Positive
Mar 13, 2025

Medical Facilities Corporation reported its financial results for the fourth quarter and full year 2024, highlighting a strong year marked by the sale of Black Hills Surgical Hospital, which bolstered its financial position. The company ended the year with a cash position of $108.5 million, repurchased shares worth $16.6 million, and fully repaid its corporate credit facility. Despite a slight decline in surgical case volumes due to an industry-wide shortage of intravenous saline fluids, the company achieved growth in income from operations and adjusted EBITDA. The sale of BHSH significantly enhanced the company’s ability to return capital to shareholders and focus on operational excellence and quality care.

Stock Buyback
Medical Facilities Corporation Completes Substantial Issuer Bid
Positive
Mar 12, 2025

Medical Facilities Corporation announced the completion of a substantial issuer bid, repurchasing approximately 14.7% of its outstanding common shares for cancellation at a total cost of around $60.7 million. This move is expected to reduce the number of issued and outstanding shares to approximately 19.5 million, potentially enhancing shareholder value and impacting the company’s market positioning. The corporation’s normal course issuer bid, which was suspended during the offer period, will resume shortly, allowing for continued share repurchases until November 2025.

Executive/Board ChangesBusiness Operations and Strategy
Medical Facilities Corporation Announces Strategic Board Changes
Neutral
Mar 3, 2025

Medical Facilities Corporation announced changes to its Board of Directors, appointing Peter Brimm and Jeremy Klaperman while Yanick Blanchard resigned. The Board will consist of five directors after the next AGM, with Brimm and Klaperman joining the Audit Committee, and Klaperman replacing Blanchard as Chair. These changes are part of a strategic refresh to enhance financial expertise and leadership as the company continues to execute its strategy.

Stock BuybackDividendsBusiness Operations and Strategy
Medical Facilities Corporation Increases Share Buyback Offer Price
Positive
Feb 24, 2025

Medical Facilities Corporation has announced an amendment to its substantial issuer bid, increasing the price range for purchasing its common shares from shareholders. The new price range is set between $16.50 and $18.00 per share, representing a significant premium over previous valuations. The offer, which aims to repurchase up to 21.3% of the company’s outstanding shares, has been extended to March 11, 2025. This move is part of the company’s strategy to return capital to shareholders, with any unused funds from the offer to be distributed as a special dividend. Shareholders who previously tendered their shares must retender them to participate under the new terms.

Financial Disclosures
Medical Facilities Corporation to Release 2024 Financial Results
Neutral
Feb 20, 2025

Medical Facilities Corporation is set to announce its fourth-quarter and full-year 2024 financial results on March 13, 2025, with an earnings call scheduled the same morning. The announcement may impact stakeholders by providing insights into the company’s financial health and strategic direction, which could influence its positioning within the healthcare industry.

Stock BuybackBusiness Operations and StrategyRegulatory Filings and Compliance
Medical Facilities Granted Flexibility in Issuer Bid by Ontario Securities Commission
Neutral
Feb 11, 2025

Medical Facilities Corporation has announced that the Ontario Securities Commission has granted an order allowing the company to extend its substantial issuer bid without needing to first take up any common shares previously deposited. While the company has not yet decided to extend the offer, the current expiration remains set for February 24, 2025. The decision has potential implications for shareholder engagement and corporate operations, as it provides flexibility in their strategic financial maneuvers.

Medical Facilities Announces $80.75M Share Buyback
Jan 17, 2025

Medical Facilities Corporation announced a substantial issuer bid to purchase and cancel up to $80,750,000 of its common shares. This decision follows the sale of Black Hills Surgical Hospital, with proceeds being used for the offer, reflecting the Board’s view that this move aligns with the company’s strategy to return capital to shareholders. The offer, structured as a modified Dutch auction, allows shareholders to tender shares within a specified price range or at a determined purchase price, ensuring the company retains sufficient resources for ongoing operations.

Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.